 WILMINGTON, DE and DELRAY BEACH, FL ACCESSWIRE March 15, 2021 NeuroRx, Inc. NeuroRx, a clinical stage-small molecule pharmaceutical company and Big Rock Partners Acquisition Corp. Big Rock NASDAQ:BRPA, a special purpose acquisition company, are pleased to announce that institutional investors have committed to a private investment of 10 million in the form of one million shares of common stock of the combined company at a price of 10.00 per share the PIPE, which will close concurrently with the previously announced proposed business combination between NeuroRx and BRPA. The PIPE transaction will provide the combined company with the capital resources to better enable it to accelerate product development of its drug portfolio. 